Hans Petter Eikesdal

Hans Petter Eikesdal

Born:         June 2^nd, 1972

e-mail:       Hans.Eikesdal@med.uib.no

Phone:       Office     +47 55976444

                  Lab         +47 55975014

Scientific work and research interests:

The identification of crucial genetic alterations for breast cancer progression and therapy resistance in breast cancer patients

Appointments

Academic Appointments:

2011->                             Senior researcher, Section for Oncology,

                                        Institute of Medicine, University of Bergen/

                                        Mohn Cancer Research Laboratoy,

                                        Haukeland University Hospital (Funded by

                                        The Norwegian Cancer Society and

                                        Bergen Medical Research Foundation)                          

2009 –                             Senior researcher, Inst. of Biomedicine,

                                        University of Bergen, Norway  

2007 (June)-2009 (June) Postdoctoral Fellow, Harvard University

                                       Division of Matrix Biology, 

                                       Beth Israel Deaconess Medical Center Boston, USA

2007 (Jan)–2007 (June)  Postdoctoral fellow, Inst. of Biomedicine,

                                       University of Bergen, Norway

Hospital Appointments:

2009-              Consultant in oncology, Haukeland University Hospital, Norway

2006-2007      Consultant in oncology, Haukeland University Hospital, Norway

2003-2006      Oncologist-in-training, Haukeland University Hospital, Norway

Awards and Honors:

2007-2008      Fulbright scholar, Harvard University

Internship and Residencies

2003-2006       Resident, Dept. of Oncology, Haukeland University Hospital, Norway

2002-2003       Compulsory Military Service as M.D., Bergen, Norway

2002                6 months internship as family practitioner, Lindaas County,

                        Hordaland, Norway

2001-2002       12 months internship, Medicine & Surgery, Voss County Hospital,

                        Norway

Education:

2002 (June) –     PhD degree.

1998 – 2000       PhD Student, The Norwegian Cancer Society (Kreftforeningen)

1998-2002:        PhD Student, University of Bergen, Norway

1991-1997:        Medical School, University of Bergen, Norway

Licensure and Certification:

2007                Board Certificate: Medical & Radiation Oncologist (Norway)

2002                DEA

1997                License: M.D. (Norway)

Scientific Publications

*    Original Reports, i.e. reports of original investigations in refereed journals.

*    Reviews and Educationally Relevant Publications:

• Eikesdal HP, Straume O, Akslen LA, Dahl O. Tumor angiogenesis and therapy directed at the neovasculature (in Norwegian). Tidsskr Nor Laegeforen 2004;124(15):1919-22.
• Eikesdal HP, Kalluri R. Drug resistance associated with antiangiogenesis therapy. Semin Cancer Biol. 2009; 19(5):310-7.
• Sund M, Nyberg P, Eikesdal HP. Endogenous matrix-derived inhibitors of angiogenesis. Pharmaceuticals 2010; 3(10):3021-3039.
• Eikesdal HP, Kalluri R. The multifaceted role of cancer associated fibroblasts in tumor progression. In: Fusenig NE, editor. Cancer associated fibroblasts and their matrix. Heidelberg: Springer; 2011. in press.

 *Publications Nationally:

• Eikesdal HP, Guren T. Tubulinhemmere. In: Dahl O, Lehne G, Baksaas I, Kvaløy S, Christoffersen T, editors. Chemotherapy (Medikamentell kreftbehandling/Cytostatikaboken, in Norwegian). 7 ed. Oslo: Dept. of Pharmacology, University of Oslo; 2009. p. 197-205.
• Eikesdal HP. Hetetokter og brystkreftrisiko. Farmasiliv. 2011; 1:38-39.

Supervision of PhD candidates:

Co-supervisor:

• Solfrid Olsen, 2007- , Dept. of Biomedicine, University of Bergen. Main supervisor: Professor Helge Wiig.
• Marek Wagner, 2010- , Dept. of Biomedicine, University of Bergen. Main supervisor: Professor Rolf Bjerkvig.

Referee work:

Acta Oncol, Int J Cancer, Fibrogenesis & Tissue Repair.

Member of committees for evaluation of dissertations and academic positions:

1. Member of committee evaluating the dissertation (PhD) of Steffen Lund Hokland, University of Aarhus, Denmark, Spring 2009.

Principal investigator in clinical trials:

Principal investigator at The Dept. of Oncology, Haukeland University Hospital for multicenter, randomized phase III clinical trial run by Amgen (Amgen-study 20030231). 2003-4.